Abstract
Introduction:The treatment of pancreatic cancer is a complex problem, due to late diagnosis, the need for specialized surgical treatment, the large number of relapses and poor survival.Objective:To evaluate the quality of life of patients with periampulary pancreatic cancer before and after pancreatoduodenectomy (PD).Material and Method:The sample was collected in the “Attikon” University General Hospital (Chaidari). It consists of 20 subjects with a mean age of 65.9 years (SD = 10,2 years). For the quality of life measurement, we used the (EORTC) QLQ-C30 version 3.0., as well as the EORTC QOL-PAN26.Results:From the sample of 20 patients who participated, full data were collected for 18 of them during the first month, 17 during the third month and 16 during the sixth month. Regarding symptoms, as they were recorded with the QLQ-30 questionnaire, there was a significant increase of fatigue, a significant reduction of pain and constipation, while economic difficulties increased. As for the mean and median values for the dimensions of the PAN-26 questionnaire during monitoring, there was a significant decrease in pancreatic and liver pain symptoms during follow-up, while the gastrointestinal symptoms increased in frequency. In addition, the body image and sexuality worsened.Conclusions:The surgical treatment of pancreatic cancer with pancreatoduodenectomy (PD), according to the early survey data using the (EORTC) QLQ-C30 version3.0, and the EORTC QOL-PAN26 questionnaires, seems to have a favorable impact on quality of life, as evidenced by the improvement of most parameters evaluated during the study period.
Highlights
The treatment of pancreatic cancer is a complex problem, due to late diagnosis, the need for specialized surgical treatment, the large number of relapses and poor survival
The surgical treatment of pancreatic cancer with pancreatoduodenectomy (PD), according to the early survey data using the (EORTC) QLQ-C30 version3.0, and the EORTC QOL-PAN26 questionnaires, seems to have a favorable impact on quality of life, as evidenced by the improvement of most parameters evaluated during the study period
The EORTC QOL-PAN26 includes 26 questions relating to disease symptoms, side effects of treatment and emotional consequences especially for pancreatic cancer (Fitzsimmons et al, 1995)
Summary
The treatment of pancreatic cancer is a complex problem, due to late diagnosis, the need for specialized surgical treatment, the large number of relapses and poor survival. Associated progression to malignancy has not been documented. Malignant tumors are mainly adenocarcinomas involving the ductal system (Avgoustis, Papageorgiou, Kintzonidis, Olympitis, & Papaioannou, 1982). International epidemiological studies suggest that over 200,000 people die annually from pancreatic cancer (PC). It is the fourth cause of death from cancer worldwide with the highest incidence and death rates observed in developed countries. Like many other types of cancer, PC is a disease of older people, with an average age of first diagnosis at 71 years. Relevant important risk factors are chronic pancreatitis due to long-term alcohol abuse, obesity, and diabetes mellitus
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
